Display options
Cite
Lagrange P, El-Bachá RD, Netter P, et al. Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress. Neurotox Res. 2001;3(4):359-68doi: 10.1007/BF03033197.
Lagrange, P., El-Bachá, R. D., Netter, P., & Minn, A. (2001). Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress. Neurotoxicity research, 3(4), 359-68. https://doi.org/10.1007/BF03033197
Lagrange, P, et al. "Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress." Neurotoxicity research vol. 3,4 (2001): 359-68. doi: https://doi.org/10.1007/BF03033197
Lagrange P, El-Bachá RD, Netter P, Minn A. Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress. Neurotox Res. 2001 Aug;3(4):359-68. doi: 10.1007/BF03033197. PMID: 14715466.
Copy Download .nbib Format: NLM
Share it on

Neurotox Res. 2001 Aug;3(4):359-68. doi: 10.1007/BF03033197.

Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress.

Neurotoxicity research

P Lagrange, R D El-Bachá, P Netter, A Minn

Affiliations

  1. UMR CNRS-Université Henri Poincaré-Nancy 1 No 7561, Laboratoire de Pharmacologie, Faculté de Médecine, BP 184, 54000 Vandoeuvre-lès-Nancy, France.

PMID: 14715466 DOI: 10.1007/BF03033197

Abstract

There is increasing evidence that an oxidative stress not only alters cellular lipids and nucleic acids, but also numerous proteins. This oxidation results in alterations of some cellular functions, either by reversible modifications allowing a post-transcriptional regulation of enzyme activities or receptor affinities, or by irreversible modifications of the protein, triggering its inactivation and destruction. In the present work, we examined the effects of an experimental oxidative stress on rat brain microsomal cytochrome P450-dependent dealkylation activities. For that purpose, superoxide anions were produced either by the NADPH-dependent redox cycling of a quinine, menadione, or by the addition of apomorphine, which produces by autoxidation both superoxide anions and apomorphine-derived quinones. The inhibition of brain cytochrome P450-dependent alkoxyresorufin O-dealkylase activities was dependent on both menadione or apomorphine concentrations. Simultaneously, an increase of microsomal carbonyl groups was recorded. Immunoblotting characterization of brain microsomal oxidized protein was carried out, using antibodies raised against 2,4-dinitrophenylhydrazine as a reagent of protein carbonyl groups, and a revelation by a chemiluminescence method. We observed an increase in cerebral CYP1A protein oxidation, related to menadione concentration, suggesting that oxidation of cytochrome P450 protein may result in its catalytic inactivation.

References

  1. Clin Exp Pharmacol Physiol. 1997 Jul;24(7):465-70 - PubMed
  2. Arch Biochem Biophys. 1994 Feb 15;309(1):24-8 - PubMed
  3. Eur Neurol. 1984;23(4):300-5 - PubMed
  4. J Biol Chem. 1997 Aug 15;272(33):20313-6 - PubMed
  5. Biochem Biophys Res Commun. 1985 Apr 16;128(1):25-33 - PubMed
  6. Methods Enzymol. 1994;233:357-63 - PubMed
  7. Arch Biochem Biophys. 1989 Dec;275(2):559-67 - PubMed
  8. Biochem Pharmacol. 1990 Nov 1;40(9):2145-51 - PubMed
  9. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):7915-22 - PubMed
  10. Neuroscience. 1993 May;54(2):287-322 - PubMed
  11. Drug Metab Rev. 1990;22(4):291-332 - PubMed
  12. Mov Disord. 1998;13 Suppl 1:24-34 - PubMed
  13. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10540-3 - PubMed
  14. Life Sci. 1998;62(2):151-63 - PubMed
  15. Free Radic Biol Med. 1999 Mar;26(5-6):620-32 - PubMed
  16. Brain Res. 1988 Jul 19;456(1):17-21 - PubMed
  17. Neurochem Res. 1989 Sep;14(9):883-7 - PubMed
  18. J Neurochem. 1992 Nov;59(5):1609-23 - PubMed
  19. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1521-5 - PubMed
  20. Free Radic Biol Med. 1999 Sep;27(5-6):667-72 - PubMed
  21. Trends Neurosci. 1994 May;17(5):192-4 - PubMed
  22. Science. 1991 Dec 13;254(5038):1597 - PubMed
  23. Acta Neurol Scand Suppl. 1989;126:47-54 - PubMed
  24. Chem Res Toxicol. 1993 Jul-Aug;6(4):430-3 - PubMed
  25. J Biol Chem. 1987 Jul 15;262(20):9895-901 - PubMed
  26. Free Radic Biol Med. 1994 Oct;17(4):321-31 - PubMed
  27. Biochem Pharmacol. 2000 Mar 1;59(5):573-82 - PubMed
  28. J Neurochem. 1997 Sep;69(3):1326-9 - PubMed
  29. Annu Rev Pharmacol Toxicol. 1999;39:67-101 - PubMed
  30. J Neurochem. 1987 May;48(5):1399-402 - PubMed
  31. Environ Health Perspect. 1990 Jul;87:237-43 - PubMed
  32. Neurosci Lett. 1987 Apr 23;76(1):58-62 - PubMed
  33. Biochem Pharmacol. 1995 Jan 31;49(3):359-65 - PubMed
  34. Ann Neurol. 1995 Sep;38(3):357-66 - PubMed
  35. Free Radic Biol Med. 1994 Oct;17(4):355-9 - PubMed
  36. Cell Mol Biol (Noisy-le-grand). 1999 Feb;45(1):15-23 - PubMed
  37. Science. 1992 Aug 28;257(5074):1220-4 - PubMed
  38. Neuropathol Appl Neurobiol. 1995 Feb;21(1):3-9 - PubMed
  39. Res Commun Chem Pathol Pharmacol. 1978 Jul;21(1):173-6 - PubMed
  40. Mutat Res. 1992 Sep;275(3-6):387-93 - PubMed
  41. Drug Metab Rev. 1995;27(3):419-48 - PubMed
  42. Brain Res. 1996 Jul 1;725(2):207-16 - PubMed
  43. Arch Biochem Biophys. 1995 Jun 20;320(1):106-14 - PubMed
  44. Biochem Pharmacol. 1994 Jul 5;48(1):155-9 - PubMed
  45. Pharmacol Ther. 1996;72(3):193-214 - PubMed
  46. Biochem Pharmacol. 1990 Mar 15;39(6):1013-8 - PubMed
  47. Neurochem Res. 1994 Sep;19(9):1131-7 - PubMed
  48. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3633-6 - PubMed
  49. Biochim Biophys Acta. 2000 Jun 2;1497(1):115-26 - PubMed

Publication Types